Neoadjuvant Radiotherapy for Non-Fixed Rectal Cancer: The Logical Choice

Thomas E. Read

doi:10.1055/s-2004-815615

Clinics in Colon and Rectal Surgery, Table of Contents

Clin Colon Rectal Surg 2003; 16(4): 243-248
DOI: 10.1055/s-2004-815615

Neoadjuvant Radiotherapy for Non-Fixed Rectal Cancer: The Logical Choice

Thomas E. Read

Division of Colon and Rectal Surgery, Department of Surgery, Western Pennsylvania Hospital, Clinical Campus of Temple University School of Medicine, Pittsburgh, Pennsylvania

Abstract

ABSTRACT

The inaccuracy of our current pretreatment staging methods, the better efficacy and lower toxicity of neoadjuvant radiotherapy as compared with postoperative radiotherapy, and the additive effect of meticulous surgical technique and radiotherapy make the treatment of patients with non-fixed, uT3N0 rectal adenocarcinoma with neoadjuvant radiotherapy the logical choice. The use of short-course radiotherapy (2000 to 2500 cGy in 5 fractions) may be the best option for the majority of these patients.

KEYWORDS

Rectal cancer - radiotherapy

Full Text

References

REFERENCES

1 Read T E, Myerson R J, Fleshman J W. et al . Surgeon specialty is associated with outcome in rectal cancer treatment. Dis Colon Rectum . 2002; 45 904-914
2 Holm T, Johansson H, Cedermark B, Ekelund G, Rutqvist L E. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg . 1997; 84 657-663
3 Porter G A, Soskolne C L, Yakimets W W, Newman S C. Surgeon-related factors and outcome in rectal cancer. Ann Surg . 1998; 227 157-167
4 Dahlberg M, Pahlman L, Bergstrom R, Glimelius B. Improved survival in patients with rectal cancer: a population-based register study. Br J Surg . 1998; 85 515-520
5 McCall J L. Total mesorectal excision: evaluating the evidence. Aust N Z J Surg . 1997; 67 599-602
6 Luna-Perez P, Reyna Huelga A, Labastida Almendaro S, Rodriguez-Coria D F, Gonzalez Macouzet J, Delgado Gallardo S. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer. Rev Invest Clin . 1999; 51 205-213
7 Dorrance H R, Docherty G M, O'Dwyer P J. Effect of surgeon specialty interest on patient outcome after potentially curative colorectal cancer surgery. Dis Colon Rectum . 2000; 43 492-498
8 McArdle C S, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ . 1991; 302 1501-1505
9 NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA . 1990; 264 1444-1450
10 Prolongation of the disease-free survival in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med . 1985; 312 1565-1573
11 Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Rectal Cancer Study Group. Cancer . 1990; 66 49-55
12 Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal Cancer Working Party. Lancet . 1996; 348 1610-1614
13 Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party. Lancet . 1996; 348 1605-1610
14 Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med . 1997; 336 980-987
15 Fleshman J W, Myerson R J. Adjuvant radiation therapy for adenocarcinoma of the rectum. Surg Clin North Am . 1997; 77 15-25
16 Marsh P J, James R D, Schofield P F. Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma: results of a prospective, randomized trial. Dis Colon Rectum . 1994; 37 1205-1214
17 Gerard A, Buyse M, Nordlinger B. et al . Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg . 1988; 208 606-614
18 Kapiteijn E, Marijnen C A, Nagtegaal I D. et al . Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med . 2001; 345 638-646
19 Fisher B, Wolmark N, Rockette H. et al . Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst . 1988; 80 21-29
20 Heald R J, Ryall R D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet . 1986; 1 1479-1482
21 Heald R J, Moran B J, Ryall R D, Sexton R, MacFarlane J K. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg . 1998; 133 894-899
22 MacFarlane J K, Ryall R D, Heald R J. Mesorectal excision for rectal cancer. Lancet . 1993; 341 457-460
23 Enker W E, Thaler H T, Cranor M L, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg . 1995; 181 335-346
24 Arenas R B, Fichera A, Mhoon D, Michelassi F. Total mesenteric excision in the surgical treatment of rectal cancer: a prospective study. Arch Surg . 1998; 133 608-611
25 Wilson S M, Beahrs O H. The curative treatment of carcinoma of the sigmoid, rectosigmoid, and rectum. Ann Surg . 1976; 183 556-565
26 Dukes C. The surgical pathology of rectal cancer. Proc R Soc Med . 1943; 37 131-144
27 Zaheer S, Pemberton J H, Farouk R, Dozois R R, Wolff B G, Ilstrup D. Surgical treatment of adenocarcinoma of the rectum. Ann Surg . 1998; 227 800-811
28 Enker W E, Havenga K, Polyak T, Thaler H, Cranor M. Abdominoperineal resection via total mesorectal excision and autonomic nerve preservation for low rectal cancer. World J Surg . 1997; 21 715-720
29 Read T E, Ogunbiyi O A, Fleshman J W. et al . Neoadjuvant external beam radiation and proctectomy for adenocarcinoma of the rectum. Dis Colon Rectum . 2001; 44 1778-1790
30 Myerson R, Picus J, Read T. Combining chemotherapy with radiation in the adjuvant care of rectal cancer: morbidity of treatment and its impact on management decisions. Perspect Colon Rectal Surg . 2000; 12 113-129
31 Read T E, McNevin M S, Gross E K. et al . Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity. Dis Colon Rectum . 2001; 44 513-522
32 Myerson R J, Genovesi D, Lockett M A. et al . Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: long-term tumor control and tolerance to treatment. Int J Radiat Oncol Biol Phys . 1999; 43 537-543
33 Marijnen C A, Kapiteijn E, van de Velde J C. et al . Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol . 2002; 20 817-825
34 Valentini V, Coco C, Cellini N. et al . Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys . 1998; 40 1067-1075
35 Marsh R D, Chu N M, Vauthey J N. et al . Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy. Cancer . 1996; 78 217-225
36 Habr-Gama A, de Souza M P, Ribeiro U J. et al . Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum . 1998; 41 1087-1096
37 Videtic G M, Fisher B J, Perera F E. et al . Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer. Int J Radiat Oncol Biol Phys . 1998; 42 319-324
38 Minsky B D, Cohen A M, Enker W E. et al . Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys . 1997; 37 289-295
39 Hyams D M, Mamounas E P, Petrelli N. et al . A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Adjuvant Breast and Bowel Project Protocol R-03. Dis Colon Rectum . 1997; 40 131-139
40 Janjan N A, Khoo V S, Abbruzzese J. et al . Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys . 1999; 44 1027-1038
41 Chan A, Wong A, Langevin J, Khoo R. Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys . 1993; 25 791-799
42 Janjan N A, Khoo V S, Rich T A. et al . Locally advanced rectal cancer: surgical complications after infusional chemotherapy and radiation therapy. Radiology . 1998; 206 131-136
43 Rich T A, Skibber J M, Ajani J A. et al . Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys . 1995; 32 1025-1029
44 Dahlberg M, Glimelius B, Graf W, Pahlman L. Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum . 1998; 41 543-551
45 Birnbaum E H, Dreznik Z, Myerson R J. et al . Early effect of external beam radiation therapy on the anal sphincter: a study using anal manometry and transrectal ultrasound. Dis Colon Rectum . 1992; 35 757-761
46 Birnbaum E H, Myerson R J, Fry R D, Kodner I J, Fleshman J W. Chronic effects of pelvic radiation therapy on anorectal function. Dis Colon Rectum . 1994; 37 909-915
47 Myerson R J, Michalski J M, King M L. et al . Adjuvant radiation therapy for rectal carcinoma: predictors of outcome. Int J Radiat Oncol Biol Phys . 1995; 32 41-50
48 Minsky B D, Cohen A M, Kemeny N. et al . The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer . 1993; 71 3486-3492
49 Mohiuddin M, Marks G. High-dose preoperative irradiation for cancer of the rectum, 1976-1988. Int J Radiat Oncol Biol Phys . 1991; 20 37-43
50 Kerman H D, Roberson S H, Bloom T S. et al . Rectal carcinoma. Long-term experience with moderately high-dose preoperative radiation and low anterior resection. Cancer . 1992; 69 2813-2819
51 Mendenhall W M, Bland K I, Copeland III M E. et al . Does preoperative radiation therapy enhance the probability of local control and survival in high-risk distal rectal cancer?. Ann Surg . 1992; 215 696-705
52 O'Connell M J, Martenson J A, Wieand H S. et al . Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med . 1994; 331 502-507
53 Tveit K M, Guldvog I, Hagen S. et al . Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg . 1997; 84 1130-1135
54 Krook J E, Moertel C G, Gunderson L L. et al . Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med . 1991; 324 709-715
55 Pahlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg . 1990; 211 187-195
56 Minsky B, Cohen A, Enker W. et al . Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer . 1994; 73 273-280
57 Gualdi G F, Casciani E, Guadalaxara A, d'Orta C, Polettini E, Pappalardo G. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: comparison with histologic findings. Dis Colon Rectum . 2000; 43 338-345
58 Garcia-Aguilar J, Pollack J, Lee S H. et al . Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum . 2002; 45 10-15
59 Marusch F, Koch A, Schmidt U. et al . Routine use of transrectal ultrasound in rectal carcinoma: results of a prospective multicenter study. Endoscopy . 2002; 34 385-390
60 Guillem J G, Puig-La Calle Jr J, Akhurst T. et al . Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum . 2000; 43 18-24
61 Sitzler P J, Seow-Choen F, Ho Y H, Leong A P. Lymph node involvement and tumor depth in rectal cancers: an analysis of 805 patients. Dis Colon Rectum . 1997; 40 1472-1476
62 Morson B C. Factors influencing the prognosis of early cancer of the rectum. Proc R Soc Med . 1966; 59 607-608
63 Minsky B D, Rich T, Recht A, Harvey W, Mies C. Selection criteria for local excision with or without adjuvant radiation therapy for rectal cancer. Cancer . 1989; 63 1421-1429
64 Brodsky J T, Richard G K, Cohen A M, Minsky B D. Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer . 1992; 69 322-326